Table II.
Adverse events profile: NDLS vs. taxotere®
| Adverse events (all grades) | NDLS, 75 mg/m | Taxotere® 75 mg/m |
|---|---|---|
| Vomiting | 10 | 22 |
| Alopecia | 35 | 26 |
| Diarrhea | 29 | 22 |
| Neutropenia | 77.5 | 52.2 |
NDLS, nanosomal docetaxel lipid suspension.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.